European Compact Advanced Radiotherapy Systems Market Research Report
- Report Code: CO 1002
- Publish Date: Upcoming
Compact advanced radiotherapy systems are well-accepted medical devices for radiotherapy in different oncology procedures. The European market for these systems, mainly driven by rapidly changing cancer treatment technology and growing number of cancer patients, was valued at $96.0 million in 2013 and is expected to reach $124.3 million by 2018, growing at a CAGR of 5.3% during the forecast period. Though they possess a small market share in the external beam radiation therapy market, compact advanced radiotherapy systems are significant technologically advanced contributors to the market.
The report on the European compact advanced radiotherapy systems market analyzes the market under three product segments: CyberKnife, Gamma Knife, and TomoTherapy. All these segments will grow until 2018 with an increase in the number of cancer patients, increased awareness of procedures, and sophisticated diagnostic techniques. With market values of $99.8 million and $96.9 million respectively, Cyber Knife and Gamma Knife segments have been contributing 40.4% and 39.3% to the total compact advanced radiotherapy devices market.
The prevalence of cancer worldwide is around 7.4 million (53%) in males and 6.7 million (47%) in females, giving a male: female ratio of 10:9. In 2012, there were an estimated 14.1 million new cases of cancer in the world. In 2014, there will be an estimated 1,665,540 new cancer cases diagnosed and 585,720 cancer deaths in the U.S. Cancer remains the second most common cause of death in the U.S., accounting for nearly 1 in every 4 deaths.
In Europe (Germany, France, Italy, Spain, U.K.), the rising rates of cancer population have been driving the market growth. The growth of the market is significantly higher in North America because it is always inclined to newer techniques while comparatively slow-moving markets such as Europe and Asia are maturing while using both, old and new technologies.
Majorly, the U.S. and Europe constitute the maximum share of compact advance radiotherapy system market. However, developing countries such as those in Asia and other regions of the world are adopting new policies to welcome this therapeutic procedure in the fight against cancer. This market is still restricted in developing countries due to the huge installation price involved. It requires highly skilled professionals for its proper application and usage. The major hindrance for these systems has been the widespread usage of other highly efficient medical robotic systems such as the da-Vinci robotic system, where no radiation is used in the treatment.
This report also provides an extensive competitive landscape of companies operating in the Euopean market for compact advanced radiotherapy systems. The main companies covered in this report are Varian Medical Systems, Elekta AB, Accuray Incorporated, Siemens, Ion Beam Applications (IBA) SA, Covidien plc, ProTom International Inc., and Mevion Medical Systems, Inc.
Segment and country-specific company shares, news and deals, mergers and acquisitions, segment-specific pipeline products, product approvals, and product recalls of major companies have also been detailed in the report.
Report Customization Options
Along with market data, you can also customize MMM offerings that are in keeping with your company’s specific needs. Customize your report on the European market for compact advanced radiotherapy systems to get an insight into all-inclusive industry standards and a deep-dive analysis of the following considerations:
Product Analysis
- Usage pattern (in-depth trend analysis) of compact advance radiotherapy systems (segment wise)
- Product matrix which gives a detailed comparison of the product portfolio of each company mapped at country and sub-segment level
- End-user adoption rate analysis of compact advance radiotherapy systems (segment wise and country wise)
- Comprehensive coverage of product approvals, pipeline products, and product recalls
Epidemiology Data
- Country-specific prevalence of prostate cancer, breast cancer and cancer of female genital organs, lung and pleura cancers, head and neck cancers, colorectal cancer, spine cancer, and brain cancer
- Country-specific patient pool of prostate cancer, breast cancer and cancer of female genital organs, lung and pleura cancers, head and neck cancers, colorectal cancer, spine cancer, and brain cancer
- Disease progression (pattern analysis)
Procedure Volume Data
- Number of prostate cancer, brain cancer, lung, and head and neck cancer surgeries performed annually in each country tracked till sub-segment level
Surgeon/Physician Perception Analysis
- Fast turnaround analysis of surgeons’ response to market events and trends
- Surgeons’ opinions about products from different companies
- Surgeons’ qualitative inputs on epidemiology data
Brand/Product Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connection tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)
Pricing Trends
- Cost analysis of compact advanced radiotherapy devices in European countries
- Investment in procedures related to prostate cancer, brain cancer, lung, and head and neck cancers
Competitive Intelligence
- Company share analysis of top players of the market in the region
- Crucial developments and strategies of companies inculcating compact advance radiotherapy devices in their portfolio
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
North American External Beam Radiotherapy Devices Market The North American External Beam Radiotherapy Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $1427.1 million in 2013 and expected to be $1571.7 million by 2018, growing at a CAGR of 2.0%. The Radiotherapy Devices Market analyzes the market of devices by 3 segments such as Compact Advanced Radiotherapy Systems, Proton Radiotherapy Systems and Electron emitting high energy linear accelerators (Linac).The prominent players in the Radiotherapy Devices Market globally are Varian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien. |
Upcoming |
|
|
European External Beam Radiotherapy Devices Market The European External Beam Radiotherapy Devices Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $702.5 million in 2013 and expected to be $784.3 million by 2018, growing at a CAGR of 2.2%. The Radiotherapy Devices Market analyzes the market of devices by 3 segments such as Compact Advanced Radiotherapy Systems, Proton Radiotherapy Systems and Electron emitting high energy linear accelerators (Linac).The prominent players in the Radiotherapy Devices Market globally are Varian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien. |
Upcoming |
|
|
Asian External Beam Radiotherapy Devices Market The Asian External Beam Radiotherapy Devices Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $699.2 million in 2013 and expected to be $919.6 million by 2018, growing at a CAGR of 5.6%. The Radiotherapy Devices Market analyzes the market of devices by 3 segments such as Compact Advanced Radiotherapy Systems, Proton Radiotherapy Systems and Electron emitting high energy linear accelerators (Linac).The prominent players in the Radiotherapy Devices Market globally are Varian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien. |
Upcoming |
